-
Panbela Therapeutics, Inc. (PBLA) Q4 2023 Earnings Call Transcript
27 Mar 2024 05:53 GMT
… the approval of gemcitabine and abraxane versus gemcitabine in the … colorectal cancer, non-small cell lung cancer and prostate cancer as well … with STK11 mutant non-muscle lung cancer. We are excited about … between 10% and 30% of lung cancers. But I will say …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … specifically accumulate in lung tumor tissues, improving drug … targeted delivery to lung tumors is a promising … .
One example is Abraxane (nab-paclitaxel). When …
-
FDA approves new Bristol Myers drug for lung cancer
16 Nov 2023 21:00 GMT
… Myers Squibb’s new lung cancer medication Augtyro, which the … with non-small cell lung cancer have this alteration, and … Opdivo transformed the treatment of lung cancer. But for patients with … lived products like Revlimid, Abraxane and Eliquis hit or approach …
-
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
27 Sep 2023 03:17 GMT
… SoC -
Small Cell Lung Cancer Program
- Preliminary data from … onvansertib with SoC (Gemzar + Abraxane). In cohort 2, patients … initiated trials in small cell lung cancer (SCLC) and triple … -cancer-and-small-cell-lung-cancer-including-single-agent-activity- …
-
Agenus (AGEN) Q4 2023 Earnings Call Transcript
14 Mar 2024 18:49 GMT
… chemotherapy agents, gemcitabine and Abraxane, as a triplet therapy. … that, for example, in lung cancer and EGFR mutant patients, … that applies to lung cancer, certain subsets of lung cancer, and that … going-forward plan for lung cancer? And also, just …
-
GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
10 Aug 2022 20:52 GMT
… of lung cancers are classified as non-small cell lung cancer (NSCLC … Abraxane resulted in significant downregulation of GNPNAT1 in lung cancer … Metastatic Ability of Lung Cancer Cells
GNPNAT1 mRNA … detected its function in lung cancer cells, and consequently …
-
Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine
12 Mar 2024 09:09 GMT
… in pancreatic and lung cancers,103,104 while … in non-small cell lung cancer, EGCG hampers autophagy by … In both bladder and lung cancers, SKN regulates autophagy … Paclitaxel-loaded albumin nanoparticles (Abraxane), liposomes loading Doxorubicin (Doxil …
-
FDA Warning Letter Cites Abraxane Manufacturing Sterility Issues
15 Nov 2022 22:04 GMT
… which manufactures the chemotherapy drug Abraxane (paclitaxel), citing ongoing contamination … cancer, advanced non-small cell lung cancer, and metastatic breast cancer.
Abraxis … remediation, and potential effects on Abraxane supply, a company spokesperson …
-
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer
29 Feb 2024 12:48 GMT
… to existing first-line treatments Abraxane® and Onivyde® in pancreatic … cytotoxic anticancer drugs such as Abraxane® and Onivyde® are … US FDA for small cell lung cancer in July last year. … expected to be effective for lung cancer, pancreatic cancer, and stomach …
-
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript
28 Feb 2024 15:54 GMT
… mutated non-small cell lung cancer or pancreatic ductal adenocarcinoma, … first-line treatment for lung cancer. We anticipate disclosing initial … for those are, gem-ABRAXANE typically response rate in … beyond pancreatic cancer and lung cancer and… Ellie Merle: …